Berkman Charles S 4

Accession 0001846253-25-000012

CIK 0001846253other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 8:50 PM ET

Size

19.4 KB

Accession

0001846253-25-000012

Insider Transaction Report

Form 4

Period: 2025-02-15

OmniAb, Inc.OABI

Berkman Charles S

Chief Legal Officer

Transactions

Exercise/Conversion
Common Stock
2025-02-16+13,541→ 372,346 total
Sale
Common Stock
2025-02-19$3.67/sh−7,255$26,626→ 356,876 total
Exercise/Conversion
Restricted Stock Units
2025-02-16−13,541→ 69,789 total
Exercise: $0.00→ Common Stock (13,541 underlying)
Award
Restricted Stock Units
2025-02-18+56,250→ 126,039 total
Exercise: $0.00→ Common Stock (56,250 underlying)
Award
Stock Option (right to buy)
2025-02-18+337,500→ 337,500 total
Exercise: $3.66Exp: 2035-02-18→ Common Stock (337,500 underlying)
Exercise/Conversion
Common Stock
2025-02-15+15,615→ 358,805 total
Sale
Common Stock
2025-02-18$3.68/sh−8,215$30,231→ 364,131 total
Exercise/Conversion
Restricted Stock Units
2025-02-15−15,615→ 83,330 total
Exercise: $0.00→ Common Stock (15,615 underlying)

Footnotes (8)

[F1]Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 15, 2023.
[F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
[F3]Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 16, 2025
[F4]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.83. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]The RSU grant vests in three substantially equal annual installments beginning on February 18, 2026.
[F8]The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Documents

1 file

4
wk-form4_1740016245.xmlPrimary
FORM 4

Issuer

OmniAb, Inc.

CIK 0001846253

→

Entity typeother

Related Parties

filerCIK 0001392266

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 8:50 PM ET
Size: 19.4 KB

View on SEC.gov